<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00947362</url>
  </required_header>
  <id_info>
    <org_study_id>169/04</org_study_id>
    <secondary_id>No grant or contract number</secondary_id>
    <nct_id>NCT00947362</nct_id>
  </id_info>
  <brief_title>Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul</brief_title>
  <acronym>rtt-ACL</acronym>
  <official_title>Phase 2 Study Electrothermocauterisation of Afghan Patients With Anthroponotic Cutaneous Leishmaniasis With and Without Pharmaceutical Chlorite Listed in the German Drug Codex (DAC N-055)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Waisenmedizin e. V. Promoting Access to Essential Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Waisenmedzin eV PACEM non-profit German NGO</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Medical Service Kabul GMS non-profit Afghan NGO</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Freiburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Microbiology Institute Clinical Microbiology Immunology and Hygiene University Clinic of Erlangen Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Waisenmedizin e. V. Promoting Access to Essential Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the randomized double blind trial with 134 patients presenting old world cutaneous
      leishmaniasis is:

        -  to evaluate the clinical efficacy of electro-thermo-cauterisation (ETC) followed by
           moist wound treatment versus ETC followed by moist wound treatment plus 0.05 %
           pharmaceutical chlorite that has been used in three European countries (Germany, Austria
           and Switzerland) in wound care management for more than 20 years;

        -  to judge whether early wound care management would present a viable improvement to the
           actual anti-parasitic treatments mostly neglecting the chronic wound problem and to
           evaluate its long-term effect on immunity through relapse control 6 months after wound
           healing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date>December 2007</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound closure time</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leishmania load parasites per gram of tissue before and after treatment</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">134</enrollment>
  <condition>Wound Healing</condition>
  <arm_group>
    <arm_group_label>ETC + DAC N-055</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ETC + physiological saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electro-thermo-coagulation</intervention_name>
    <arm_group_label>ETC + DAC N-055</arm_group_label>
    <arm_group_label>ETC + physiological saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DAC N-055</intervention_name>
    <description>moist wound treatment plus 0.05 % pharmaceutical chlorite</description>
    <arm_group_label>ETC + DAC N-055</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>physiological saline</description>
    <arm_group_label>ETC + physiological saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least one suspected lesion positive in Giemsa smear

        Exclusion Criteria:

          -  patients previously treated for leishmania
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>German Medical Service</name>
      <address>
        <city>Kabul</city>
        <country>Afghanistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Afghanistan</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2009</study_first_submitted>
  <study_first_submitted_qc>July 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2009</study_first_posted>
  <last_update_submitted>July 27, 2009</last_update_submitted>
  <last_update_submitted_qc>July 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Professor Dr. Dr. Kurt-Wilhelm Stahl President of Waisenmedzin eV</name_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leishmaniasis</mesh_term>
    <mesh_term>Leishmaniasis, Cutaneous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

